EncroVision Prometheus Biosciences, Inc. (NASDAQ:RXDX) is a clinical-stage biotechnology company specializing in immunological diseases, including UC (ulcerative colitis) and CD (Crohn’s disease). On December 7, 2022, Prometheus reported positive Phase 2 results for PRA023 and […]
Scharfsinn86 Investment Thesis The Hyliion Holdings Corp. (NYSE:HYLN) story is interesting, but there are better companies for investment. HYLN may eventually turn a profit, but the risks are too high for the potential reward as […]
stockcam Thesis Spotify (NYSE:SPOT) continues to take market share in nicely growing market – and the company’s Q3 results highlight that macro concerns are not slowing the global expansion of music streaming industry. CEO and […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.